NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo Efficacy

T. J. Dougherty, A. Nayar, J. V. Newman, S. Hopkins, G. G. Stone, M. Johnstone, A. B. Shapiro, M. Cronin, F. Reck, D. E. Ehmann
  • Antimicrobial Agents and Chemotherapy, February 2014, ASM Journals
  • DOI: 10.1128/aac.02778-13

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1128/aac.02778-13

In partnership with: